- Home
- SEPN
SEPN
SEPTERNA INC
as 05-30-2025 4:00pm EST
Stocks
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
| Founded: | 2022 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 311.6M | IPO Year: | 2024 |
| Target Price: | $27.00 | AVG Volume (30 days): | 2.5M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.17 - $28.99 | Next Earning Date: | 05-15-2025 |
| Revenue: | $977,000 | Revenue Growth: | 108.76% |
| Revenue Growth (this year): | -66.79% | Revenue Growth (next year): | N/A |
Latest SEPTERNA INC News
SEPN Breaking Stock News: Dive into SEPN Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Septerna to Present at Jefferies Global Healthcare Conference
Argus Research
9 days ago
Daily – Vickers Top Insider Picks for 05/22/2025
Zacks
10 days ago
Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?
Argus Research
10 days ago
Daily – Vickers Top Insider Picks for 05/21/2025
Argus Research
11 days ago
Daily – Vickers Top Insider Picks for 05/20/2025
Argus Research
15 days ago
Daily – Vickers Top Insider Picks for 05/16/2025
GlobeNewswire
15 days ago
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
Zacks
16 days ago
ETFs to Capitalize on the Novo Nordisk-Septerna Deal
Compare SEPN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SEPN SEPTERNA INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.